10-12 September 2018 //  Lancaster Royal Hotel, London


Frederic Revah

Frederic Revah

President; Chief Executive Officer, YposKesi; Genethon

Frédéric Revah is Chief Executive Officer of Genethon a non-profit R&D organization dedicated for more than twenty years to developing gene therapy treatments for rare diseases from research to clinical development, and President of YposKesi one the largest industrial platforms for pharmaceutical production of gene- and cell-therapy products created in nov 2016. Frédéric Revah has more than twenty five years’ experience in biotech and pharmaceutical industry, where he held several corporate managerial positions, as well as in academic research. He obtained his Ph.D. at the Institut Pasteur / Université Paris V, and graduated from the Ecole Polytechnique engineering school.


2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad